Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States

BACKGROUND: This study analyses treatment patterns, health care resource utilization (HCRU), and costs in patients with myelofibrosis (MF) and a subgroup treated with ruxolitinib (RUX). MATERIALS AND METHODS: Treatment patterns, all-cause and MF-related HCRU, and costs were analyzed in adults with M...

Descripción completa

Detalles Bibliográficos
Autores principales: Copher, Ronda, Kee, Arianna, Gerds, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Health Outcomes and Economics of Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914486/
https://www.ncbi.nlm.nih.gov/pubmed/35274711
http://dx.doi.org/10.1093/oncolo/oyab058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914486/
https://www.ncbi.nlm.nih.gov/pubmed/35274711
http://dx.doi.org/10.1093/oncolo/oyab058

Ejemplares similares